-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Thrombotic thrombocytopenic purpura (TTP) is a potentially life-threatening disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, ADAMTS13 (a de-integrin with a platelet-reactive protein 1 repeat, member 13) activity severely reduced or absent, and associated with varying degrees of organ dysfunction
.
A single-center retrospective cohort study conducted immune-mediated TTP (iTTP)
for all children and adolescents attending a children's health center in Atlanta, Georgia, between 2001 and 2021.
Figure 1: Patient's response
to treatment.
Figure 2: Overview of immunomediated thrombotic thrombocytopenic purpura (iTTP): follow-up time, relapse, and comorbidities
.
Original Source:
Graciaa, S, Adeagbo, S, Fong, G, et al.